ISREC – Swiss Institute for Experimental Cancer Research

Enhancing breast cancer diagnosis and treatment

Published:19.07.24 — Addressing problems with diagnosing and treating breast cancer, scientists at EPFL have developed EMBER, a tool that integrates breast cancer transcriptomic data from multiple databases. EMBER can improve precision oncology by accurately predicting molecular subtypes and therapy responses.

Antibody-peptide inhibitor conjugates: a new path for cancer therapy

Published:03.06.24 — Cancer treatments often struggle with balancing efficacy and side effects. A new study by EPFL scientists offers a promising solution using antibody-peptide inhibitor conjugates to target specific cell types and block the activity of cancer-promoting enzymes called cathepsins.

How and why different cell division strategies evolve

Published:27.05.24 — EPFL scientists, in collaboration with researchers at EMBL Heidelberg, have discovered that a group of marine protists (eukaryotic organisms) closely related to animals use open or closed mitosis based on their life cycle stages, suggesting that the way animal cells perform cell division evolved long before animals themselves.